Vaccines |
Hepatitis A Vaccine (Human Diploid Cell), Inactivated
Dosage form |
0.5ml/vial & prefilled syringe for children 1.0ml/vial & prefilled syringe for adults |
Inoculations process |
1-15 years old for children, Above 16 years old for adults 0, 6 month |
Recombinant Hepatitis B Vaccine (Saccharomyces cerevisiae)
Dosage form |
0.5ml/vial for children 1ml/vial for adults |
Inoculations process |
0, 1, 6 months for children |
Diphtheria, Tetanus, Acellular Pertussis and Haemophilus Influenzae Type b Combined Vaccine
Dosage form |
0.5ml/vial DTaP 0.5ml/vial Hib lyophilized powder |
Inoculations process |
3, 4, 5 months + 18 month |
Group ACY W135 Meningococcal Polysaccharide Vaccine
Dosage form |
0.5ml/vial |
Inoculations process |
Above 2 years old and adults |
Measles and Rubella Combined Vaccine , Live
Dosage form |
0.5ml/vial |
Inoculations process |
Above 8 months |
Influenza Vaccine (Split Virion), Inactivated
Dosage form |
0.25ml/vial for children 0.5ml/vial for adults |
Inoculations process |
6-36 months for children above 36 months for adults |
Enterovirus Type 71 Vaccine (Vero Cell), Inactived
Dosage form |
0.5ml/vial 0.5ml/prefilled syringe |
Inoculations process |
6 months to 5 years old |
Rabies Vaccine for Human Use (Human Diploid Cell), Freeze-dried
Dosage form |
1ml/vial |
Inoculations process |
0, 3, 7, 14, 28 days after bitted |
Varicella Vaccine, Live
Dosage form |
0.5ml/vial 0.5ml/prefilled syringe |
Inoculations process |
1 year old to 12 years old |
Inactivated Poliomyelitis Vaccine , Sabin Strains
Dosage form |
0.5ml/vial |
Inoculations process |
2, 3, 4 months + 18 months |
13-Valent Pneumococcal Conjugate Vaccine (PCV-13)
Dosage form |
0.5ml/prefilled syringe |
Inoculations process |
6 weeks to 5 years old and above 50 years old |
23-Valent Pneumococcal Polysaccharide Vaccine (PPV-23)
Dosage form |
0.5ml/vial 0.5ml/prefilled syringe |
Inoculations process |
Above 2 years old |
Bivalent Human Papillomavirus Vaccine (HPV-2)
Dosage form |
0.5ml/vial 0.5ml/prefilled syringe |
Inoculations process |
0, 1, and 6 months |
Monoclonal Antibody
Generic | Originator | Brand name | Target | Indication |
---|---|---|---|---|
Adalimumab | Abbott | Humira | TNF | RA, SA |
Ado-Trastuzumab | Roche | Kadcyla | HER-2 | Oncology |
Aflibercept | Sanofi | Eylea | VEGF | wAMD, RVO, DME, DR |
Bevacizumab | Roche | Avastin | VEGF | Oncology |
Cetuximab | Imclone/BMS | Erbitux | EGFR | Oncology |
Densosumab | Amgen | Prolia | PANKL | Oncology |
Evolocumab | Amgen | Repatha | PCSK-9 | High Cholestrol |
Infliximab | Johnson&Johnson | Remicade | TNF | RA, IBD |
Ipilimumab | BMS | Yervoy | CTLA-4 | Oncology |
Nivolumab | BMS | Opdivo | PD-1 | Oncology |
Omalizumab | Novartis | Xolair | IgE | Asthma |
Pembrolizumab | MSD | Keytruda | PD-1 | Oncology |
Pertuzumab | Roche | Perjeta | HER-2 | Oncology |
Rituximab | Roche | Mabthera | CD20 | Oncology |
Tocilizumab | Roche | Actemra | IL-6 | RA |
Trastuzumab | Roche | Herceptin | HER-2 | Oncology |
Peptides
Product Name | CAS No. | Stardand | Documentation |
---|---|---|---|
Albiglutide | 782500-75-8 | In-house | TP |
Argireline | 616204-22-9 | In-house | TP |
Atosiban | 90779-69-4 | In-house | TP |
Bivalirudin | 128270-60-0 | In-house | DMF |
Carbetocin | 37025-55-1 | In-house | DMF |
Caspofungin Acetate | 179463-17-3 | In-house | DMF |
Gonadorelin Acetate | 33515-09-2 | USP,BP,EP | TP |
Degarelix acetate | 214766-78-6 | In-house | DMF |
Deslorelin | 57773-65-6 | In-house | TP |
Desmopressin | 16679-58-6 | USP,BP,EP | GMP,DMF |
Dulaglutide | 923950-08-7 | In-house | TP |
Eptifibatide | 148031-34-9 | In-house | DMF |
Exenatide | 141732-76-5 | In-house | TP |
Glatiramer Acetate | 147245-92-9 | In-house | TP |
Glucagon | 16941-32-5 | USP,BP,EP | GMP |
Goserelin Acetate | 145781-92-6 | USP,BP,EP | DMF |
Leuprorelin | 53714-56-0 | BP,EP | TP |
Linaclotide | 851199-59-2 | In-house | DMF |
Liraglutide | 204656-20-2 | In-house | DMF |
Nesiritide | 124584-08-3 | In-house | DMF |
Octreotide Acetate | 83150-76-9 | CP,USP,BP,EP | GMP |
Oxytocin | 50-56-6 | EP,USP | CEP,GMP |
Pramlintide | 151126-32-8 | In-house | GMP |
Protirelin | 24305-27-9 | BP,EP | GMP |
Salmon Calcitonin | 47931-85-1 | CP,USP,BP,EP | GMP |
Somatostatin | 38916-34-6 | CP,BP,EP | GMP |
Terlipressin | 14636-12-5 | CP | GMP,EDMF |
Thymopentin | 69558-55-0 | CP | GMP |
Thymosin α1 | 62304-98-7 | CP | GMP |
Triptorelin | 57773-63-4 | In-house | GMP |
Vasopressin | 113-79-1 | USP,In-house | TP |
Others
Product Name | Specification |
Erythropoietin | 2000IU/ml, 3000IU/ml, 4000IU/ml, 6000IU/ml, 10000IU/ml |
Filgrastim | 75mcg/0.5ml 150mcg/0.5ml 300mcg/ml |
Human Albumin 20% | 20g/vial (100ml) 12.5g/vial (62.5ml) 10g/vial (50ml) 5g/vial (25ml) 2g/vial (10ml) |
Human Immunoglobulin for Intravenous Injection (IVIG) 5% | 10g/vial (200ml) 5g/vial (100ml) 2.5g/vial (50ml) 1.25g/vial (25ml) 1g/vial (20ml) 0.5g/vial (10ml) |
Human Hepatitis B Immunoglobulin | 500IU/vial (5ml) 250IU/vial (2.5ml) |
Human Tetanus Immunoglobulin | 500IU/vial (5ml) 250IU/vial (2.5ml) |
Human Rabies Immunoglobulin | 500IU/vial (5ml) 200IU/vial (2ml) 100IU/vial (1ml) |
Insulin Aspart | USP,BP,EP |
Insulin Glargine | USP,EP |
Insulin Degludec | In-house |
Recombinant Insulin Human | USP,EP,CP 1500IU/vial |
Tetanus Antitoxin | 3000IU/vial 5000IU/vial 10000IU/vial |